ACC Current Journal Review

Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction
pp. 7-7(1)
Authors: Krumholz H.M.; Chen Y.T.; Wang Y.; Radford M.J.

Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina
pp. 7-7(1)
Author: The Organization to Assess Strategies for Ischemic Syndromes OASIS Investigators

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement
pp. 8-8(1)
Authors: Turpie A.G.; Gallus A.S.; Hoek J.A.; for the Pentasaccharide Investigators

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
pp. 8-8(1)
Authors: Merli G.; Spiro T.E.; Olsson C.G.; et al; for the Enoxaparin Clinical Trial Group

Sex differences in 2-year mortality after hospital discharge for myocardial infarction
pp. 8-9(2)
Authors: Vaccarino V.; Krumholz H.M.; Yarzebski J.; Gore J.M.; Goldberg R.J.

Refractory angina: current options
pp. 10-14(5)
Author: Conti C.R.

Figure 1. A licensable pilot?
pp. 15-15(1)

Figures 2 and 3. The answer is ...
pp. 16-16(1)

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid lowering therapy
pp. 25-25(1)
Authors: Zambon A.; Deeb S.S.; Brown B.G.; Hokanson J.E.; Brunzell J.D.

Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk
pp. 25-25(1)
Authors: von Eckardstein A.; Schulte H.; Cullen P.; Assmann G.

Physical activity and coronary heart disease in women. Is ''no pain, no gain'' passe?
pp. 25-26(2)
Authors: Lee I.M.; Rexrode K.M.; Cook N.R.; Manson J.E.; Buring J.E.

Hormone replacement therapy, prothrombotic mutations, and the risk of innocent nonfatal myocardial infarction in postmenopausal women
pp. 26-26(1)
Authors: Psaty B.M.; Smith N.L.; Lemaitre R.N.; et al

Cardiovascular disease, interleukin-6, and risk of mortality in older women. The Women's Health and Aging Study
pp. 26-27(2)
Authors: Vopato S.; Guralnik J.M.; Ferruci L.; et al

History of anxiety disorders is associated with a decreased likelihood of angiographic coronary disease in women with chest pain: the WISE study
pp. 27-27(1)
Authors: Rutledge T.; Reis S.E.; Olson M.; Owens J.; et al

Postmenopausal hormone therapy and risk of stroke. The Heart and Estrogen-Progestin Replacement Study (HERS)
pp. 27-28(2)
Authors: Simon J.A.; Hsia J.; Cauley J.A.; et al; for the HERS Research Group

Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects
pp. 28-28(1)
Authors: Kario K.; Matsuo T.; Kobayashi H.; Hoshide S.; Shimada K.

Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study
pp. 28-29(2)
Authors: Kiechel S.; Egger G.; Mayr M.; et al

Review of first 5 years of screening for familial hypercholesterolemia in The Netherlands
pp. 29-29(1)
Authors: Umans-Eckenhausen M.A.W.; Defesche J.C.; Sijbrands E.J.G.; Scheerder R.L.J.M.; Kastelein J.J.P.

Beyond lipids: markers of coronary risk and events
pp. 30-34(5)
Author: Kuller L.H.

Effects of early use of atenolol or captopril on infarct size and ventricular volume. A double-blind comparison in patients with anterior acute myocardial infarction
pp. 42-42(1)
Authors: Galcera-Tomas J.; Castillo-Soria J.; Villegas-Garcia M.; et al

Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction
pp. 42-42(1)
Authors: Cerisano G.; Bolognese L.; Buonamici P.; et al

Prediction of mortality using dobutamine echocardiography
pp. 42-43(2)
Authors: Marwick T.H.; Case C.; Sawada S.; et al

Enhanced detection of reversible perfusion defects by Tc-99m sestabmibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease
pp. 43-43(1)
Authors: Soman P.; Taillefer R.; DePuey E.G.; Udelson J.E.; Lahiri A.

Complete bundle branch block as an independent predictor of all-cause mortality: report of 7073 patients referred for nuclear exercise testing
pp. 43-44(2)
Authors: Hesse B.; Diaz L.A.; Snader C.E.; Blackstone E.H.; Lauer M.S.

The progression of fenfluramine-associated valvular heart disease assessed by echocardiography
pp. 44-44(1)
Authors: Mast S.T.; Jollis J.G.; Ryan T.; Anstrom K.J.; Crary J.L.

Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy
pp. 44-44(1)
Authors: Weissman N.J.; Panza J.A.; Tighe J.F.; Gwynne J.T.

Clinical assessment of LV diastolic filling by Doppler echocardiography
pp. 45-49(5)
Authors: Nagueh S.F.; Zoghbi W.A.

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
pp. 53-53(1)
Authors: Dao Q.; Krishnaswamy P.; Kazanegra R.; et al

Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes
pp. 53-54(2)
Authors: Sato Y.; Yamada T.; Taniguchi R.; et al

Dilated cardiomyopathy in dialysis patients-beneficial effects of carvedilol: a double-blind, placebo-controlled trial
pp. 54-54(1)
Authors: Cice C.; Ferrara L.; Di Benedetto A.; et al

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
pp. 54-54(1)
Authors: Gullestad L.; Aass H.; Fjeld J.G.; et al

Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome
pp. 55-55(1)
Authors: Deng M.C.; Loebe M.; El-Banayosy A.; et al

Detection and prediction of acute heart transplant rejection with the myocardial T₂ determination provided by a black-blood magnetic resonance imaging sequence
pp. 55-55(1)
Authors: Marie P.Y.; Angio M.; Carteaux J.P.; et al

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study
pp. 61-61(1)
Authors: Sousa J.E.; Costa M.A.; Abizaid A.; et al

Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty
pp. 61-62(2)
Authors: Verin V.; Popowski Y.; de Bruyne B.; et al

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting
pp. 62-62(1)
Authors: Leon M.B.; Teirstein P.S.; Moses J.W.; et al

Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent
pp. 62-63(2)
Authors: McGrath P.D.; Wennberg D.E.; Dickens J.D.; et al

Argentine randomized study: coronary angioplasty with stenting vs. coronary artery bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one year follow-up results
pp. 63-63(1)
Authors: Rodriguez A.; Bernardi V.; Navia J.; et al

Non Q-wave myocardial infarction following thrombolytic therapy: a comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial
pp. 63-64(2)
Authors: Wexler L.F.; Blaustein A.S.; Lavori P.W.; et al

Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris
pp. 64-64(1)
Authors: Collet J.P.; Montalescot G.; Lison L.; et al

Percutaneous mitral balloon valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy
pp. 64-65(2)
Authors: De Souza J.A.M.; Martinez E.E.; Ambrose J.A.; et al

Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis
pp. 65-65(1)
Authors: Roubin G.S.; New G.; Iyer S.S.; et al

Sealing vs. suturing devices
pp. 66-67(2)
Author: Sanborn T.A.

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia
pp. 69-69(1)
Authors: Priori S.G.; Napolitano C.; Tiso N.; et al

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia
pp. 69-69(1)
Authors: Laitinen P.J.; Brown K.M.; Piippo K.; et al

Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people
pp. 69-70(2)
Authors: Corrado D.; Basso C.; Buja G.; Nava A.; Rossi L.; Thiene G.

Drug-induced QT prolongation in women during the menstrual cycle
pp. 70-70(1)
Authors: Rodriguez I.; Kilborn M.J.; Liu X.K.; Pezzullo J.C.; Woosley R.L.

''Stable'' ventricular tachycardia is not a benign rhythm. Insights from the Antiarrhythmics Vs. Implantable Defibrillators (AVID) registry
pp. 70-70(1)
Authors: Raitt M.H.; Renfroe E.G.; Epstein A.E.; et al

Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection. Results and technical considerations
pp. 70-71(2)
Authors: Wilkoff B.; Kuhlkamp V.; Volosin K.; et al

Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome
pp. 71-71(1)
Authors: Brugada J.; Aguinaga L.; Mont L.; Betriu A.; Mulet J.; Sanz G.

Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K⁺ channels
pp. 71-72(2)
Authors: Brundel B.J.J.M.; Van Gelder I.C.; Henning R.; et al

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation
pp. 72-72(1)
Author: Khan I.A.

Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia
pp. 72-73(2)
Authors: Alboni P.; Tomasi C.; Menozzi C.; et al

Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
pp. 73-73(1)
Authors: Madrid A.H.; Ortega J.; Rebollo J.G.; et al

Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease. Isolated channels between scars allow ''focal'' ablation
pp. 73-73(1)
Authors: Nakagawa H.; Shah N.; Matsudaira K.; et al

Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery
pp. 81-81(1)
Authors: Leavitt B.J.; O'Connor G.T.; Olmstead E.M.; et al; for the Northern New England Cardiovascular Disease Study Group

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery
pp. 81-82(2)
Authors: Newman M.F.; Kirchner J.L.; Phillips-Bute B.; et al; for the Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators

Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization
pp. 82-82(1)
Authors: Hemmingway H.; Crook A.M.; Feder G.; et al

Early mortality and morbidity of bilateral vs. single internal thoracic artery revascularization: propensity and risk modeling
pp. 82-82(1)
Authors: Ioannidis J.P.A.; Galanos O.; Katritis D.; et al

Prediction of operative mortality after valve replacement surgery
pp. 82-83(2)
Authors: Edwards F.H.; Peterson E.D.; Coombs L.P.; et al

Superiority of clopidogrel vs. aspirin in patients with prior cardiac surgery
pp. 83-83(1)
Authors: Bhatt D.L.; Chew D.P.; Hirsh A.T.; Ringleb P.A.; Hacke W.; Topol E.J.

Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis
pp. 83-84(2)
Authors: Massel D.; Little S.H.

Guideline snapshot
pp. 85-85(1)

The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients
pp. 91-91(1)
Authors: Mair D.D.; Puga F.J.; Danielson G.K.

Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation
pp. 91-92(2)
Authors: Ghai A.; Harris L.; Harrison D.A.; Webb G.D.; Siu S.C.

Ventricular preexcitation in children and young adults. Atrial myocarditis as a possible trigger of sudden death
pp. 92-92(1)
Authors: Basso C.; Corrado D.; Rossi L.; Thiene G.

Balloon angioplasty for obstructed modified systemic pulmonary artery shunts and pulmonary artery stenoses
pp. 92-92(1)
Authors: Wang J.K.; Wu M.H.; Chang C.I.; Chiu I.S.; Lue H.C.

Major coronary artery anomalies in a pediatric population: incidence and clinical importance
pp. 93-93(1)
Authors: Davis J.A.; Cecchin F.; Jones T.K.; Portman M.A.

Preventive and primary care of the adult with congenital heart disease
pp. 94-98(5)
Author: Kovach J.A.